Correlation Between Novartis and Biogen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novartis and Biogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Biogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Biogen Inc, you can compare the effects of market volatilities on Novartis and Biogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Biogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Biogen.

Diversification Opportunities for Novartis and Biogen

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Novartis and Biogen is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Biogen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biogen Inc and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Biogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biogen Inc has no effect on the direction of Novartis i.e., Novartis and Biogen go up and down completely randomly.

Pair Corralation between Novartis and Biogen

Considering the 90-day investment horizon Novartis AG ADR is expected to generate 0.79 times more return on investment than Biogen. However, Novartis AG ADR is 1.27 times less risky than Biogen. It trades about 0.19 of its potential returns per unit of risk. Biogen Inc is currently generating about -0.06 per unit of risk. If you would invest  9,498  in Novartis AG ADR on December 26, 2024 and sell it today you would earn a total of  1,540  from holding Novartis AG ADR or generate 16.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Novartis AG ADR  vs.  Biogen Inc

 Performance 
       Timeline  
Novartis AG ADR 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Novartis AG ADR are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Novartis unveiled solid returns over the last few months and may actually be approaching a breakup point.
Biogen Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Biogen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Novartis and Biogen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novartis and Biogen

The main advantage of trading using opposite Novartis and Biogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Biogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will offset losses from the drop in Biogen's long position.
The idea behind Novartis AG ADR and Biogen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.